Gastroesophageal Reflux and Pulmonary Fibrosis in Scleroderma
- 1 March 2009
- journal article
- research article
- Published by American Thoracic Society in American Journal of Respiratory and Critical Care Medicine
- Vol. 179 (5), 408-413
- https://doi.org/10.1164/rccm.200808-1359oc
Abstract
Rationale: Interstitial lung disease (ILD) in patients with systemic sclerosis (SSc) is associated with increased morbidity and mortality. Gastroesophageal reflux (GER) is considered a contributing factor in the pathogenesis of ILD. Objectives: To characterize GER (acid and nonacid) in patients with SSc with and without ILD. Methods: Patients with SSc underwent pulmonary high-resolution computer tomography (HRCT) scan and 24-hour impedance–pH monitoring off–proton pump inhibitor therapy. The presence of pulmonary fibrosis was assessed using validated HRCT-scores. Reflux monitoring parameters included number of acid and nonacid reflux episodes, proximal migration of the refluxate, and distal esophageal acid exposure. Unless otherwise specified, data are presented as median (25th–75th percentile). Measurements and Main Results: Forty consecutive patients with SSc (35 female; mean age, 53 yr; range, 24–71; 15 patients with diffuse and 25 with limited SSc) were investigated; 18 (45%) patients with SSc had pulmonary fibrosis (HRCT score ≥ 7). Patients with SSc with ILD had higher (P < 0.01) esophageal acid exposure (10.3 [7.5–15] vs. 5.2 [1.5–11]), higher (P < 0.01) number of acid (41 [31–58] vs. 19 [10–23]) and nonacid (25 [20–35] vs. 17 [11–19]) reflux episodes, and higher (P < 0.01) number of reflux episodes reaching the proximal esophagus (42.5 [31–54] vs. 15 [8–22]) compared with patients with SSc with normal HRCT scores. Pulmonary fibrosis scores (HRCT score) correlated well with the number of reflux episodes in the distal (r2 = 0.637) and proximal (r2 = 0.644) esophagus. Conclusions: Patients with SSc with ILD have more severe reflux (i.e., more reflux episodes and more reflux reaching the proximal esophagus). Whether or not the development of ILD in patients with SSc can be prevented by reflux-reducing treatments needs to be investigated.This publication has 50 references indexed in Scilit:
- S1065 Correlation Between Pulmonary Fibrosis and GERD in Scleroderma (SSc) Patients: Studies Using 24-Hour Ambulatory Intraluminal pH-Impedance (MII-pH)Gastroenterology, 2008
- Gastro-oesophageal reflux and aspiration of gastric contents in adult patients with cystic fibrosisGut, 2008
- Extra‐esophageal manifestations of gastroesophageal refluxOral Diseases, 2007
- Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allograftsThorax, 2005
- Review article: extraoesophageal manifestations of gastro-oesophageal reflux diseaseAlimentary Pharmacology & Therapeutics, 2005
- Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas refluxGut, 2004
- Esophageal involvement and pulmonary manifestations in systemic sclerosisArthritis & Rheumatism, 2001
- Interstitial Lung Disease of Systemic SclerosisInternational Reviews of Immunology, 1995
- Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitisDigestive Diseases and Sciences, 1992
- Neurological complications of systemic sclerosis-a report of three cases and review of the literatureClinical and Experimental Dermatology, 1990